Grantham Mayo Van Otterloo & Co. LLC Has $241,000 Position in Cardinal Health, Inc. $CAH

Grantham Mayo Van Otterloo & Co. LLC cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 92.2% in the third quarter, Holdings Channel.com reports. The fund owned 1,533 shares of the company’s stock after selling 18,001 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC’s holdings in Cardinal Health were worth $241,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. SJS Investment Consulting Inc. increased its stake in shares of Cardinal Health by 1,363.6% during the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. American Capital Advisory LLC lifted its stake in shares of Cardinal Health by 5,200.0% in the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. Vermillion & White Wealth Management Group LLC boosted its holdings in Cardinal Health by 55.0% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after purchasing an additional 71 shares in the last quarter. Finally, Quent Capital LLC acquired a new position in Cardinal Health during the third quarter worth $35,000. 87.17% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft raised their target price on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a report on Tuesday, November 18th. Barclays increased their price objective on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. Mizuho raised their price objective on Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research note on Friday, February 6th. Wells Fargo & Company boosted their target price on Cardinal Health from $237.00 to $256.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $245.67.

Cardinal Health Price Performance

CAH stock opened at $219.24 on Friday. The stock has a market capitalization of $51.59 billion, a price-to-earnings ratio of 31.55, a price-to-earnings-growth ratio of 1.39 and a beta of 0.65. The company has a 50-day moving average of $216.60 and a two-hundred day moving average of $191.39. Cardinal Health, Inc. has a 52-week low of $120.72 and a 52-week high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, February 5th. The company reported $2.63 EPS for the quarter, topping analysts’ consensus estimates of $2.31 by $0.32. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.The business had revenue of $65.63 billion for the quarter, compared to analyst estimates of $64.88 billion. During the same period in the previous year, the company posted $1.93 earnings per share. The firm’s revenue for the quarter was up 18.8% on a year-over-year basis. Equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be given a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, April 1st. Cardinal Health’s payout ratio is currently 29.35%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.